On the public citation graph

https://doi.org/10.2139/ssrn.4165603

0 signed · 24 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/dmrr.2530openalex-extracted
The New insights from DPP‐4 inhibitors: their potential immune modulatory function in autoimmune diabetes
inferredcites →https://doi.org/10.1002/sim.5984openalex-extracted
The use of propensity score methods with survival or time‐to‐event outcomes: reporting measures of effect similar to those used in randomized experiments
inferredcites →https://doi.org/10.1016/j.coi.2012.07.005openalex-extracted
Host defenses against bacterial lower respiratory tract infection
inferredcites →https://doi.org/10.1038/s41574-020-0399-8openalex-extracted
Dipeptidyl peptidase 4 inhibitors in the treatment of type 2 diabetes mellitus
inferredcites →https://doi.org/10.1038/s41598-018-19949-zopenalex-extracted
A systematic review and meta-analysis: Association between MGMT hypermethylation and the clinicopathological characteristics of non-small-cell lung carcinoma
inferredcites →https://doi.org/10.1055/s-0032-1333467openalex-extracted
Global Epidemiology of Tuberculosis
inferredcites →https://doi.org/10.1056/nejmoa1307684openalex-extracted
Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus
inferredcites →https://doi.org/10.1080/00273171.2011.568786openalex-extracted
An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies
inferredcites →https://doi.org/10.1093/cid/ciab209openalex-extracted
Completion Rate and Safety of Programmatic Screening and Treatment for Latent Tuberculosis Infection in Elderly Patients With Poorly Controlled Diabetic Mellitus: A Prospective Multicenter Study
inferredcites →https://doi.org/10.1093/qjmed/hcv096openalex-extracted
Short-term dipeptidyl peptidase-4 inhibitor use increases the risk of herpes zoster infection in Asian patients with diabetes
inferredcites →https://doi.org/10.1111/dom.14142openalex-extracted
Exposure to dipeptidyl‐peptidase 4 inhibitors and the risk of pneumonia among people with type 2 diabetes: Retrospective cohort study and meta‐analysis
inferredcites →https://doi.org/10.1111/ecc.13648openalex-extracted
Validating the adapted Diabetes Complications Severity Index in claims data.
inferredcites →https://doi.org/10.1111/imr.12030openalex-extracted
CD 4+ T‐cell subsets and host defense in the lung
inferredcites →https://doi.org/10.1111/joim.12197openalex-extracted
Propensity scores for confounder adjustment when assessing the effects of medical interventions using nonexperimental study designs
inferredcites →https://doi.org/10.1136/bmj.l5657openalex-extracted
Alternative approaches for confounding adjustment in observational studies using weighting based on the propensity score: a primer for practitioners
inferredcites →https://doi.org/10.1164/rccm.200604-571stopenalex-extracted
An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases
inferredcites →https://doi.org/10.1210/jc.2012-2396openalex-extracted
Mechanism of Action of DPP-4 Inhibitors—New Insights
inferredcites →https://doi.org/10.1371/journal.pone.0139367openalex-extracted
Use of Dipeptidyl-Peptidase-4 Inhibitors and the Risk of Pneumonia: A Population-Based Cohort Study
inferredcites →https://doi.org/10.1371/journal.pone.0175925openalex-extracted
Prevalence and associated factors of tuberculosis and diabetes mellitus comorbidity: A systematic review
inferredcites →https://doi.org/10.21037/apm-20-278openalex-extracted
Effects of dipeptidyl peptidase-4 inhibitor treatment doses on tuberculosis in patients with diabetes: a long-term nationwide population-based cohort study
inferredcites →https://doi.org/10.2174/18756417mtaxgodqqyopenalex-extracted
Type 2 Diabetes and its Impact on the Immune System
inferredcites →https://doi.org/10.2337/dc10-1771openalex-extracted
Use of Dipeptidyl Peptidase-4 Inhibitors and the Reporting of Infections: A Disproportionality Analysis in the World Health Organization VigiBase
inferredcites →https://doi.org/10.2337/diabetes.54.10.2988openalex-extracted
Dipeptidyl Peptidase IV Inhibition for the Treatment of Type 2 Diabetes
inferredcites →https://doi.org/10.3389/fphar.2021.731453openalex-extracted
The Roles of Dipeptidyl Peptidase 4 (DPP4) and DPP4 Inhibitors in Different Lung Diseases: New Evidence
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.